Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 2Small Cell Lung Carcinoma 1Pleural Effusion, Malignant 1Neoplasm, Residual 1NSCLC 1Lung Neoplasms 1

Interventions

Drug Therapy 4Pemetrexed 3Carboplatin 3osimertinib 2Radiotherapy 2toripalimab 1tislelizumab 1sugemalimab 1spartalizumab 1sintilimab 1pembrolizumab 1cemiplimab 1aflutinib 1Vinorelbine 1Radiosurgery 1Platinum 1Paclitaxel 1Gemcitabine 1Docetaxel 1Cisplatin 1Chemotherapy, Adjuvant 1Anterior Temporal Lobectomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × NSCLC × sugemalimab × Clear all
NCT07247227 2025-11-25

Real-world First-line Sugemalimab-Chemotherapy in Advanced NSCLC

Peking Union Medical College

Phase NA Recruiting
150 enrolled
Thoracic

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon âš¡